You searched for "outcomes"
Should intravitreal steroids be used in the initial treatment of post-op endophthalmitis?
1 October 2018
| Eulee Seow
|
EYE - Cataract, EYE - Refractive
|
adjuvant intravitreal dexamethasone, cataract surgery, postoperative bacterial endophthalmitis, randomized controlled trial
Endophthalmitis following cataract surgery is one of the most feared complications, and can have significant impact on the visual outcomes of patients. The role of steroids in the management of endopthalmitis is controversial. The aim of this paper was to...
IOL power calculation formulas for myopic eyes undergoing cataract surgery after excimer laser
The authors set out to compare the accuracy of four no-history formulas: Barrett True-K, Haigis-L, Shammas-PL, and Triple-S to calculate the intraocular lens (IOL) power in eyes with previous myopic photorefractive keratectomy or laser in situ keratomileusis, according to their...Use of botulinum toxin A in the treatment of intermittent exotropia
In this prospective cohort study, the authors aimed to evaluate the efficiency of botulinum toxin A (BTA) injection in the treatment of intermittent exotropia (IXT) and examine factors affecting treatment outcomes. Seventy-four patients diagnosed with any type of IXT were...Efficacy of combined vitrectomy with intravitreal corticosteroid injection for ERM
1 December 2022
| Sofia Rokerya
|
EYE - Vitreo-Retinal
|
Dexamethasone, Epiretinal membrane, Intravitreal injection, Triamcinolone, Vitrectomy
In this study the authors evaluated the efficacy of vitrectomy combined with corticosteroid injection for idiopathic epiretinal membrane (ERM). A systematic literature review was conducted by searching three electronic databases, PubMed, Embase and Medline, up to 2020 for relevant studies....
Pilot trial of Fluoxetine for post-stroke homonymous hemianopia
3 April 2024
| Lauren R Hepworth
|
EYE - Neuro-ophthalmology
The authors present a pilot randomised placebo controlled double blind trial assessing 20mg fluoxetine once daily for 90 days versus placebo in stroke survivors with isolated homonymous hemianopia. Exclusion criteria were extensive in terms of pre-existing ophthalmic or neurologic disease,...
Cost-effectiveness framework discussion for vision screening
The authors present a discussion paper on hypothetical, but representative, examples of post-referral costs that may result from different screening options up to the point of discharge from specific services. Data was taken from a recent (2019) systematic review (with...Beyond ‘Shield and Ship’: a novel device (Eye-Aid) to provide temporary aqueous tamponade
4 February 2025
| Ben Smith
|
EYE - Cornea
The authors present a pilot efficacy study of the novel Eye-Aid device in a porcine model of full-thickness corneal wounds to mitigate anterior chamber collapse in the forward military environment. Currently, the ‘Shield and Ship’ paradigm taught to military healthcare...
Dexmedetomidine vs remifentanil for reduction of postoperative agitation
Postoperative agitation is a common anaesthetic complication in children with a significant impact to care and outcomes. The authors studied preschool children to compare the effect of intravenous administration of dexmedetomidine and remifentanil on postoperative agitation following strabismus surgery under...High levels of public trust in optometry supports extended services closer to home, says AOP
New research published by the General Optical Council (GOC) last week shows high levels of confidence in optical practitioners.Specsavers joins IAPB to advocate for better eye health
The International Agency for the Prevention of Blindness (IAPB) proudly welcomes Specsavers as a pivotal new member, joining the global alliance for the eye health sector in the fight against avoidable sight loss. "For more than four decades, Specsavers has...Randomisation, confounding & observational methods in ophthalmic epidemiology
1 June 2022
| Skanda Rajasundaram, Dalia Abdulhussein, Christopher Bentley (Prof), Minak Bhalla
|
EYE - General
Randomisation and confounding Understanding the relationship between an exposure and an outcome of interest is the central challenge in ophthalmic epidemiology. The exposure may be aetiological, taking the form of a putative risk biological factor, or therapeutic, in the form...